Hypertension Trial, Recruiting NCT07400549 Sponsor: China National Center for Cardiovascular Diseases Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07400549
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older.
  • People who are willing to take part and can sign a consent form.
  • People who have been diagnosed with at least one of the following four conditions: high blood pressure (where blood pressure readings are consistently high, or where four or more blood pressure medications are being taken and blood pressure is controlled); type 2 diabetes or high blood sugar (based on specific blood sugar or HbA1c test results, or currently taking diabetes medication, with HbA1c between 6.5% and 13.0%); high cholesterol or abnormal blood fats (based on specific test results, or currently taking cholesterol-lowering medication); or high uric acid levels in the blood (based on specific test results taken on two separate days, or currently taking uric acid-lowering medication — thresholds differ for men, postmenopausal women, and premenopausal women, confirm with trial site).
  • People who are able to use a smartphone.
  • People who are permanent local residents and receive basic public health services at a designated community health centre or township hospital.
  • People who have not been doing regular moderate to vigorous exercise (meaning at least 30 minutes per session, at least 3 days per week) in the past three months.

Who may not be able to join:

  • People with a history of, or a current episode of, heart or brain blood vessel disease — including angina, heart attack, coronary bypass surgery, stroke or mini-stroke, peripheral artery disease requiring surgery, serious heart rhythm problems, uncontrolled irregular heartbeat, severe heart failure, a thickened heart muscle condition, or a history of large aneurysms or aneurysm surgery.
  • People who currently have cancer, or who have had cancer within the past five years.
  • People who have a condition that makes exercise unsafe, such as certain bone or joint diseases.
  • People with serious lung conditions, including asthma, COPD, reduced lung capacity (due to obesity, pregnancy, or spinal problems), or cystic fibrosis.
  • People with nerve or muscle diseases that affect movement, such as muscular dystrophy, polio, or dementia.
  • People with serious mental health conditions, including schizophrenia, bipolar disorder, eating disorders, or depression that required a hospital stay within the past six months.
  • People with movement or neurological disorders such as Huntington's disease, Parkinson's disease, dystonia, or certain forms of epilepsy.
  • People with serious health conditions where life expectancy is estimated to be less than 24 months.
  • People who are planning to move out of the local area within the next three months.
  • People who have taken part in another exercise or physical activity program within the six months before the screening visit.
  • People who are currently enrolled in another randomised clinical trial.
  • People whose situation, in the judgement of the trial investigator, might make it difficult to follow the trial's requirements (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86+ 88319206

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in mean daily step count

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov